Medical Weight Loss of New York(Fayetteville, NY)
常见问题
What is medical weight loss?
Medical weight loss is a comprehensive approach to lose weight, keep it off and reverse diseases. It involves focus in 4 areas including nutrition, exercise, behavioral modification, and medication management.
How is your medical weight loss program different from others?
Dr. Scinta and her providers have over 18 years of weight loss expertise under their belts. They understand the need for an individualized and comprehensive approach that addresses nutritional, behavioral, exercise, and medical needs.
How does MWL customize my weight loss plan?
We start with a detailed two-part physical, including a review of your bloodwork, medical history, medications, and past experiences to create a unique plan specific to you.
诊所简介
Medical Weight Loss of New York in Fayetteville, NY offers GLP-1 peptides (semaglutide, tirzepatide), hormone therapy under board-certified obesity medicine ...
Medical Weight Loss of New York, located in Fayetteville, NY, operates under the medical direction of Dr. Wendy Scinta, MD, MS, a board-certified obesity medicine physician who brings specialized training in the physiological and metabolic factors underlying weight management. Dr. Scinta’s dual credentials in medicine and medical science inform the clinic’s evidence-based approach to treating obesity as a chronic disease rather than a willpower issue. The practice serves patients throughout the Syracuse metropolitan area and Central New York region, offering in-person consultations where providers conduct comprehensive metabolic assessments, review medical history, and design individualized treatment protocols based on each patient’s hormonal profile, body composition, and weight loss objectives.
The clinic’s pharmaceutical toolkit centers on three FDA-approved GLP-1 receptor agonists: semaglutide, tirzepatide, and liraglutide. Semaglutide is prescribed for patients requiring once-weekly dosing with proven efficacy in appetite regulation and glycemic control. Tirzepatide, a dual GIP/GLP-1 receptor agonist, is utilized for patients who may benefit from enhanced metabolic effects beyond traditional GLP-1 therapy alone. Liraglutide serves as an alternative for patients who respond better to daily injectable protocols or have specific contraindications to longer-acting formulations. Medical Weight Loss of New York integrates these peptide therapies with hormone replacement protocols when indicated, addressing thyroid dysfunction, sex hormone imbalances, or cortisol dysregulation that may impede weight loss progress. Each medication regimen is titrated based on patient tolerance, side effect profile, and measurable outcomes tracked through regular follow-up appointments.
Dr. Scinta and her clinical team, which includes experienced nurse practitioners, conduct initial consultations that typically involve laboratory work to assess metabolic markers, hormone levels, and cardiovascular risk factors. Patients receive structured nutrition guidance tailored to their medication protocol, with meal planning recommendations designed to optimize peptide therapy effectiveness while maintaining adequate protein intake and micronutrient density. The practice does not employ generic meal replacement programs; instead, providers educate patients on sustainable dietary patterns that align with their cultural preferences, work schedules, and family dynamics. Follow-up visits allow for medication adjustments, side effect management, and accountability check-ins that address both physiological responses and behavioral patterns affecting adherence.
Patients at the Fayetteville clinic report that the office environment facilitates open dialogue about weight-related health concerns without judgment, and that nurse practitioners take time to answer questions about medication mechanisms, expected timelines, and how to navigate social situations while on GLP-1 therapy. The practice emphasizes realistic goal-setting, typically targeting 1-2 pounds of fat loss per week once therapeutic dosing is achieved, and providers discuss the likelihood of weight plateaus, the role of resistance training in preserving lean mass, and strategies for long-term weight maintenance after initial loss phases. Hormone replacement therapy consultations address symptoms such as fatigue, mood changes, and metabolic slowdown that often accompany perimenopause, menopause, or andropause, with bioidentical hormone options discussed when appropriate for the patient’s risk profile and treatment goals.
Medical Weight Loss of New York requires in-person visits for initial consultations and periodic follow-ups, allowing Dr. Scinta and her team to perform physical examinations, review vital signs, and assess treatment response through direct patient interaction. The clinic’s location in Fayetteville provides accessible care for residents of Syracuse, Manlius, Dewitt, and surrounding Onondaga County communities. With over 200 patient reviews reflecting a 4.9-star rating, the practice has established a reputation in Central New York for combining advanced peptide therapies with comprehensive metabolic and hormonal assessment, delivered by a board-certified obesity medicine specialist who understands the complex interplay between weight, hormones, and overall health outcomes.
